Globus Medical shareholders approve share issuance for NuVasive merger; 99.92% vote in favor

GLOBUS MEDICAL INC

99.92% of votes cast approved share issuance; 99.66% of Class A and 100% of Class B voted for.
Exchange ratio: 0.75 Globus Class A shares for each NuVasive share; NuVasive holders to own ~28% of combined co.
Combined company will have over 5,000 employees focused on musculoskeletal solutions and enabling technologies.
Merger expected to close after regulatory clearance and satisfaction of other customary conditions.
Globus Medical to report Q1 2023 earnings on May 4, 2023.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

GLOBUS MEDICAL INC shareholders approved Approval of issuance of shares in connection with the Merger at the 2023-04-27 meeting.

Proposal: merger approval
Outcome: passed
Meeting: 2023-04-27

Exact text from the filing

Globus Share Issuance Proposal . To vote to approve the issuance of shares of Globus Class A Common Stock in connection with the Merger (the “Globus Share Issuance Proposal”). Votes For Votes Against Abstentions 287,038,438 210,302 2,666,263

View on SEC.gov

Browse all shareholder votes →

GLOBUS MEDICAL INC filing history →

Source: SEC EDGAR

accession 0001193125-23-123358

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.